International Invited Speakers
Howard A. Rowley, MD
Professor (Tenure), Department of Radiology
Joseph F. Sackett Professor of Radiology
Chair, MRI Safety Committee
University of Wisconsin, School of Medicine and Public Health
Dr Howard A. Rowley is a Professor of Radiology, Neurology, and Neurosurgery; Chief of Neurological MRI; and the Joseph F. Sackett Professor of Radiology at the University of Wisconsin School of Medicine and Public Health. He obtained his MA and MD degrees from Washington University in St. Louis, and multi-specialty training at the University of California, San Francisco. He is board-certified and active in the disciplines of neurology, radiology, and neuroradiology. Dr. Rowley is internationally recognized for his contributions to stroke trials, dementia research, and advanced imaging techniques. He is first past president of the American Society of Neuroradiology (ASNR). Dr. Rowley has received multiple outstanding speaker awards for his lectures and webcasts covering a wide range of neuroradiology topics.
Claude Sirlin, MD
Professor of Radiology, UC San Diego Health
Co-Director of the Cancer Imaging Program at Moores Cancer Center
Chair of the Liver Imaging Reporting and Data System Committee for the American College of Radiology
Co-Director of the Radiologist Clinician-Scientist Training Program
San Diego, USA
Claude B. Sirlin, MD, is an NIH-funded clinician scientist who specializes in liver imaging, metabolic imaging and imaging of hepatobiliary cancers. Dr. Sirlin founded and directs UC San Diego Health’s Liver Imaging Group, which actively collaborates with hepatologists, surgeons, pathologists and statisticians to advance screening, diagnosis, treatment and outcomes of individuals with liver disease. He is also the chair of the Liver Imaging Reporting and Data System Committee for the American College of Radiology and co-director of the Clinician-Scientist Radiology Residency Program in his university. As Professor and Vice Chair of Translational Research in the Department of Radiology, Dr. Sirlin mentors medical students, residents, fellows, and junior faculty at UC San Diego School of Medicine. Over the last 16 years, he has supervised more than 150 trainees in clinical imaging research. He has published more than 240 peer-reviewed articles and is a reviewer for multiple radiology journals.
Dr Jones & Partners
Chair, Abdominal Radiology Group of Australia and New Zealand (ARGANZ)
Dr Kirsten Gormly is a consultant radiologist at Dr Jones and Partners Medical Imaging, South Australia. She has special interests in oncology imaging and pelvic MRI including rectal cancer, prostate cancer, female urology and benign and malignant gynaecological conditions. She completed a fellowship year at Chelsea & Westminster Hospital, London was trained in rectal MRI by Prof Gina Brown while working at the Royal Marsden Hospital, London. She is involved in teaching and research and promotes collaboration between radiologists and other speciality groups.
Farzan Siddiqui MD, PhD
Vice-Chair, Radiation Oncology
Director, Head and Neck Radiation Oncology
Department of Radiation Oncology
Henry Ford Health System
Clinical Associate Professor, Radiation Oncology, Wayne State University, Detroit, MI
Adjunct Associate Professor, School of Dentistry, University of Detroit Mercy, Detroit, MI
Dr Siddiqui is a Board Certified Radiation Oncologist specializing in the treatment of Head and Neck cancers. Along with the Medical Physics division at the Henry Ford Hospital, he has been very actively involved with their "adaptive radiation therapy" group and serves as the clinical lead on all such projects within the department.Dr Siddiqui did his first residency in Radiation Oncology at Tata Memorial Hospital in Mumbai, India. His post-graduate thesis was on the use of brachytherapy for the treatment of head and neck cancers and its role in minimizing xerostomia. His PhD at Colorado State University was in the use of hyperthermia and interleukin-12 gene therapy delivered using an adenoviral vector. Dr Siddiqui’s second residency in Radiation Oncology was at Henry Ford Hospital, Detroit, MI. Upon graduation he joined the faculty at Ohio State University as the Director of Head and Neck Radiation Oncology. In 2012, he moved back to Henry Ford Health System as the Vice-Chair of Radiation Oncology and Director of Head and Neck Radiation Therapy. In this role he has been intimately involved with the development and establishment of a multi-disciplinary head and neck cancer team including ENT surgeons, medical oncologists, radiation oncologists, speech-language pathologists, dieticians, neuroradiologists, psychologists and other integral members of the team.
At a national level, Dr Siddiqui serves on the Educational Committee and Scientific Committee for the American Society of Radiation Oncology (ASTRO). He was the vice-chair of the ASTRO annual meeting abstract review committee for 3 years (2012-2014) and is the Chair for the next 3 years (2015-2017). He is also a member of the American College of Radiology Appropriateness Criteria Expert Panel for Head and Neck cancers. Dr Siddiqui has authored and co-authored 5 guidelines papers as part of this effort, and also co-authored papers on adaptive radiation therapy for head and neck cancers.
National Invited Speakers
Head, School of Nursing
University of Auckland
Professor Alexandra McCarthy was appointed Head, School of Nursing, at University of Auckland in April 2017. A Co-director of the Women’s Wellness after Cancer Program based at the Menzies Institute, Griffith University, she also holds adjunct Professor roles at Griffith University and Queensland University of Technology, and is Visiting Fellow at Princess Alexandra Hospital, Brisbane. Prior to her relocation to Auckland Professor McCarthy was jointly appointed as the inaugural Chair of Cancer Nursing, Princess Alexandra Hospital and School of Nursing, Queensland University of Technology. She has extensive practical experience in acute cancer care, which informs her strong international profile in cancer research. McCarthy’s research has two streams. The first focuses upon health promotion and risk reduction in long-term survivors of cancer. The second focuses on the assessment and management of the toxicities of acute cancer treatments, with an emphasis on the older cancer patient.